CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 749.9% in March

CV Sciences, Inc. (OTCMKTS:CVSIGet Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totaling 71,807 shares, a growth of 749.9% from the March 15th total of 8,449 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 2,402,985 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Stock Performance

OTCMKTS:CVSI traded up $0.00 during trading hours on Friday, reaching $0.04. 113,011 shares of the stock were exchanged, compared to its average volume of 1,152,928. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10. The firm has a 50 day moving average of $0.05 and a 200 day moving average of $0.04. The company has a current ratio of 1.03, a quick ratio of 0.21 and a debt-to-equity ratio of 0.26.

CV Sciences Company Profile

(Get Free Report)

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.

Read More

Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.